每周股票复盘：惠泰医疗（688617）回购进展公布

Core Viewpoint - Huatai Medical (688617) has seen a significant increase in stock price, closing at 265.66 yuan, up 9.2% from the previous week, indicating positive market sentiment and performance in the medical device sector [1] Company Announcements Summary - As of December 31, 2025, Huatai Medical has repurchased 402,976 shares, accounting for 0.29% of the total share capital, with a total expenditure of 99.92 million yuan [1] - The company announced a share repurchase plan on December 9, 2025, with a total budget of 200 million to 250 million yuan, a maximum repurchase price of 315 yuan per share, and a duration of 10 months from December 9, 2025, to October 8, 2026 [1] - The highest repurchase price recorded was 256 yuan per share, while the lowest was 235 yuan per share, with the repurchased shares intended for employee stock ownership plans or equity incentives [1]